News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: BCS Paladin post# 267691

Monday, 07/04/2016 3:24:43 PM

Monday, July 04, 2016 3:24:43 PM

Post# of 347009
That new medical device ( re: Brigitte Phan/Donald Bollella / Ramon Valencia) probably has the new BP player for Peregrine every so anxious to stryker a deal

PS Targeting will be required for much all diseases, even implants, bone reconstruction, and heck.... if our liver decreases in function by 50%+ within out lifetime, maybe that is the reason for other troubles....

I still can't believe that CALICO can be shut out of this picture but I also believe that AstraZeneca or Merck could easily be acquired by the true believers of PS Targeting

Who will it be

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y